Pancreatic cyst
![Pancreatic cyst meeting](/content/dam/munichre/global/images/royalty-free/GettyImages-872235596.jpg/_jcr_content/renditions/cropped.3_to_1.jpg./cropped.3_to_1.jpg)
properties.trackTitle
properties.trackSubtitle
May 2024
This series presents individual medical cases that feature challenging conditions, uncommon diseases, or an unusual presentation of symptoms. Below, we summarize a case, explain our research and analysis, and suggest an underwriting recommendation. Munich Re’s team of global medical directors routinely conducts rigorous analyses of the latest medical advances so that primary insurers and society alike can benefit from evidence-informed risk assessments. It is our hope that exploring compelling cases will foster a greater understanding of medical research and awareness of new medical innovations and emerging risks while ultimately expanding insurability.
Case: Pancreatic cyst
Munich Re medical's response
What exactly is a “serous cystadenoma” of the pancreas?
- Serous cystic neoplasms (SCNs) or serous cystadenomas are non-mucinous lesions with characteristic findings on imaging. They are multi-cystic with a honeycomb appearance, sometimes described as a “bunch of grapes.” Most commonly seen in women over 60 years old, these lesions have a negligible risk for malignancy.
How common is this condition, and what are some mortality and morbidity concerns?
- Pancreatic cystic neoplasms are being detected more frequently and are mostly found incidentally due to the widespread use of abdominal imaging such as CT scans or MRIs.
- These cystic neoplasms of the pancreas are further subcategorized as either “mucin-producing cysts” (which may have malignant potential) or “non-mucin-producing cysts.”
- Mucin-producing cysts, such as intraductal papillary mucinous neoplasms and mucinous cystic neoplasms, may have malignant potential and must be monitored carefully.
- Serous cystadenomas are in the non-mucin-producing cyst category and are considered benign with no malignant potential.
Final recommendation
![Gina Guzman Gina Guzman](/content/dam/munichre/global/images/staff-and-events-(data-protection-relevant)/Gina%20Guzman.jpg/_jcr_content/renditions/original./Gina%20Guzman.jpg)
![Tim Meagher Tim Meagher](/content/dam/munichre/global/images/staff-and-events-(data-protection-relevant)/Tim%20Meagher%202019.jpg/_jcr_content/renditions/original.image_file.120.120.file/Tim%20Meagher%202019.jpg)
![Bradley Heltemes Bradley Heltemes](/content/dam/munichre/global/images/staff-and-events-(data-protection-relevant)/Brad%20Heltemes.jpg/_jcr_content/renditions/original./Brad%20Heltemes.jpg)
![John F. White III John F. White III](/content/dam/munichre/contentlounge/website-pieces/experts/John-White.png/_jcr_content/renditions/original./John-White.png)